Q3 2024 EPS Estimates for Ontrak, Inc. Reduced by Roth Capital (NASDAQ:OTRK)

Ontrak, Inc. (NASDAQ:OTRK) – Analysts at Roth Capital dropped their Q3 2024 EPS estimates for shares of Ontrak in a report released on Thursday, October 10th. Roth Capital analyst J. Aschoff now expects that the company will post earnings of ($1.56) per share for the quarter, down from their prior estimate of ($1.50). The consensus estimate for Ontrak’s current full-year earnings is ($7.35) per share. Roth Capital also issued estimates for Ontrak’s Q4 2024 earnings at ($1.41) EPS, FY2024 earnings at ($7.39) EPS, FY2025 earnings at ($3.67) EPS, FY2026 earnings at ($0.36) EPS, FY2027 earnings at $0.06 EPS and FY2028 earnings at $0.10 EPS.

Separately, Roth Mkm reduced their target price on shares of Ontrak from $4.00 to $3.00 and set a “buy” rating for the company in a research note on Friday, August 9th.

Ontrak Stock Performance

OTRK stock opened at $2.44 on Monday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 3.64 and a current ratio of 3.64. The stock has a market cap of $117.04 million, a P/E ratio of -0.61 and a beta of 2.56. The firm has a 50 day simple moving average of $0.88 and a 200 day simple moving average of $0.49. Ontrak has a 52 week low of $1.81 and a 52 week high of $21.29.

Ontrak (NASDAQ:OTRK) last released its earnings results on Thursday, August 8th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.09). The firm had revenue of $2.45 million during the quarter, compared to analysts’ expectations of $2.60 million. Ontrak had a negative return on equity of 238.43% and a negative net margin of 222.54%. During the same period last year, the business earned ($1.84) earnings per share.

Ontrak Company Profile

Ontrak, Inc operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need.